Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ready2Change-Methamphetmine (R2C-M): A Randomised Controlled Trial of a Telephone-delivered Intervention to Reduce Methamphetamine Use

NCT04713124 is registered in ClinicalTrials.gov with Turning Point as lead sponsor.

NCT NCT04713124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ready2Change-Methamphetmine (R2C-M): A Randomised Controlled Trial of a Telephone-delivered Intervention to Reduce Methamphetamine Use
Lead sponsor
Turning Point
Phase
Not applicable
Overall status
Completed
Start date
February 4, 2021
Completion date
January 25, 2024
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder